Company Overview and News

 
Hydro One’s planned merger with U.S. energy firm Avista passes another hurdle

2018-05-22 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

1
AVA / Avista Corp. 8-K (Current Report)

2018-05-21 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549

 
AVA / Avista Corp. 8-K (Current Report)

2018-05-18 sec.gov
Document

 
AVA / Avista Corp. 424B2 (Prospectus)

2018-05-16 sec.gov
424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-209714 CALCULATION OF REGISTRATION FEE

 
AVA / Avista Corp. FWP

2018-05-15 sec.gov
FWP Filed Pursuant to Rule 433 Registration No. 333-209714 May 15, 2018 AVISTA CORPORATION $3

 
AVA / Avista Corp. 8-K (Current Report)

2018-05-15 sec.gov
Document

1
AVA / Avista Corp. 424B3 (Prospectus)

2018-05-15 sec.gov
424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-209714 The information contained in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securit

 
AVA / Avista Corp. 8-K (Current Report)

2018-05-10 sec.gov
Document

 
Hydro One and Avista Reach Settlement in Principle in Oregon Merger Case

2018-05-08 globenewswire
TORONTO and SPOKANE, Wash., May 08, 2018 (GLOBE NEWSWIRE) -- Hydro One Limited (“Hydro One”) (TSX:H) and Avista Corporation (“Avista”) (NYSE:AVA) have reached a significant milestone in the regulatory approval process of the proposed merger. A settlement in principle with all parties in the Oregon proceeding has been reached. The parties intend to file the full settlement agreement with the Public Utility Commission of Oregon (“OPUC”) later this month.

 
Hydro One and Avista receive Federal Communications Commission approval for proposed merger

2018-05-07 globenewswire
TORONTO and SPOKANE, Wash., May 07, 2018 (GLOBE NEWSWIRE) -- Hydro One Limited (“Hydro One”) (TSX:H) and Avista Corporation (“Avista”) (NYSE:AVA) announced that on May 4, 2018, the companies received the Federal Communications Commission’s (“FCC”) consent to close their merger.

 
Top Ten Utility Stocks For Dividend Growth And Income

2018-05-06 seekingalpha
It's been sixteen months since I last covered the top dividend growth stocks in the utility sector.

 
Ford’s claim that Hydro One customers are on the hook for $50 million in potential serverance a “flat out lie,” Energy Mnister says

2018-05-04 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Avista Corporation 2018 Q1 - Results - Earnings Call Slides

2018-05-03 seekingalpha
The following slide deck was published by Avista Corporation in conjunction with their 2018 Q1 earnings call.

 
Avista Corp's (AVA) CEO Scott Morris on Q1 2018 Results - Earnings Call Transcript

2018-05-02 seekingalpha
Welcome to the 2018 Q1 Earnings Conference Call. My name is Adrian, and I'll be your operator for today's call. At this time all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session. [Operator Instructions] Please note that this conference is being recorded.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 05379B107